Bloom Energy
- Country
- Ownership
- -
- Employees
- 2.3K
- Market Cap
- -
- Introduction
Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.
FDA Approves Monthly IV Maintenance Dosing for Leqembi, Eases Treatment Burden for Alzheimer's Patients
• The FDA has approved a monthly intravenous (IV) maintenance dose for Leqembi, offering a more convenient treatment schedule for early Alzheimer's disease.
• Patients completing the initial 18-month biweekly IV treatment can transition to monthly dosing, potentially improving long-term adherence and quality of life.
• Approval is based on data modeling showing sustained clinical and biomarker benefits with monthly dosing, addressing the continuous neurotoxic processes of Alzheimer's.
• Leqembi, developed by Eisai and Biogen, is now approved in multiple countries, offering a significant advancement in managing early Alzheimer's disease.
Vertex's ALYFTREK Approved by FDA as Next-Generation Cystic Fibrosis Treatment
• The FDA has approved Vertex's ALYFTREK for cystic fibrosis (CF) in patients aged 6 years and older with specific genetic mutations.
• ALYFTREK is a once-daily triple combination therapy, offering a more convenient dosing schedule compared to existing treatments.
• Clinical trials demonstrated ALYFTREK's non-inferiority to TRIKAFTA in lung function and significant improvement in sweat chloride levels.
• The drug's label includes a boxed warning for potential liver injury, necessitating regular liver function monitoring.
© Copyright 2025. All Rights Reserved by MedPath